Methods: We determined antibody to hepatitis B surface antigen (anti-HBs) at 4-13 years of age in 363 low risk children who had been vaccinated starting at birth with hepatitis B vaccine.

Study: AGA Clinical Practice Guideline on the Prevention and Treatment of Hepatitis B Virus ... either positive for the HBV surface antigen (HBsAg) or HBV core antibody (anti-HBc).

The US Food and Drug Administration (FDA) has granted breakthrough therapy designation to Bluejay Therapeutics’ fully human immunoglobulin G1 (IgG1) monoclonal antibody, brelovitug, to treat ...

Brelovitug is a fully human immunoglobulin G1 monoclonal antibody that targets hepatitis B virus surface antigen (HBsAG). By binding to HBsAg, brelovitug is expected to neutralize and clear hepatitis ...

Single-dose administration of E6F6 could profoundly suppress the levels of hepatitis B surface antigen (HBsAg ... and only forms a smaller antibody–viral particle immune complex with limited ...

Conclusion: Cirrhotic CHB patients had lower antibody titers to inactivated SARS-CoV ... The inclusion criteria were as follows: a) over 18 years of age; b) were positive for hepatitis B surface ...

A total of 118 recommendations based on expert consensus were published regarding the treatment of hidradenitis suppurativa ...

The phase 3 waveLINE-010 trial (NCT06717347) evaluating the combination of zilovertamab vedotin, an investigational antibody-drug conjugate (ADC ... Those who are hepatitis B surface antigen-positive ...

Hepatitis B surface antigen (HBsAg), core total antibody (anti-HBc) and surface antibody (anti-HBs) were detected by the Architect immunoassay (Abbott Diagnostics, Germany). Hepatitis B infection was ...

MGD010 exhibited pharmacokinetic properties of an antibody ... vivo BCR-induced B-cell activation (1). To further understand the potential for MGD010 to modulate ongoing immune responses, the impact ...